The U.S. Court of Appeals for the Federal Circuit invalidated on Friday the patent for the once-a-week version of Merck's blockbuster osteoporosis drug Fosamax. Under the ruling, generic competition ...
Mar. 23 -- WEDNESDAY, Feb. 6 (HealthDay News) -- The U.S. Food and Drug Administration has approved the first generic equivalents of Fosamax (alendronate sodium), Merck & Co.'s osteoporosis drug. In a ...
In the United States, the safety of prescription drugs is overseen along two parallel pathways. Federal regulation is provided by the Food and Drug Administration (FDA), which works to ensure the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback